Transforming Oncology with Predicine’s AAA Liquid Biopsy Solutions – Global Clinical Trials & CDx Development
Time: 2:00 pm
day: Day One Track B PM
Details:
- LBx technology innovation in ctDNA and cfRNA, Breakthrough Device Designation granted by FDA
- Blood/urine/tissue-based NGS solution, including mutation and methylation-based MRD detection
- Global clinical trial and CDx development in the US, China, and the ROW
